The following email is the one that AOL would not allow the original author
to send -- nor could RMNews send it via AOL -- There must be something in
the article that triggers an AOL "stop command".
===========RUMOR MILL NEWS AGENCY===========
>From Ru Mills, Editor in Chief
The following was forwarded by Patricia Doyle from the Emerging Diseases
webpage. Longtime RMNews readers will remember that RMNews was the first to
post that the West Nile Virus was an experiment in bio-terrorism.
(While the original RMNews article is no longer on the Egroups page -- it is
quoted in the following articles. They are long, so read the breaking news
sent from Patricia first)
http://www.rumormillnews.com/cgi-bin/config.pl?read=38
http://www.rumormillnews.com/cgi-bin/config.pl?read=37
http://www.egroups.com/message/RuMills/118
###
Major West Nile Virus Development-please forward- Breaking News
Date: 08/03/2000 3:34:17 AM Pacific Daylight Time
From: labgal_5@yahoo.com (Patricia Doyle)
To: rayelan@aol.com
Hello Raye: As I have been saying all along, the west nile was released as
1. a bioterrorism preparedness real life drill, and
2. FOR PROFIT.
They chose to release the virus in New York for the preparedness
simulation.
Plum Island had also been working on a JE family encephalitis vaccine and
wrote up the paper on Jan. 12, 1999. On that document they stated they had
tested it on human volunteers. 2 encephalitis vaccines. How did they
know that a virus not endemic to the US would be needed. A really
profitable vaccine would be one that would be needed in the US. Patricia
Subject: Major West Nile Virus Development-please forward-Breaking News
WNV Vaccine Announced by Co. Linked to Giuliani
by Robert Lederman [Major new development in the West Nile Virus issue]
From: FINANCIAL TIMES LONDON 8/1/2000
Peptide Therapeutics, the UK biotech company, said it had been awarded a
$3m grant to develop a new vaccine to combat the mosquito-borne West Nile
virus, which killed seven.
The vaccine will be developed at OraVax, Peptide's US subsidiary, using
the company's proprietary ChimeriVax technology." [see below for their
detailed press release]
For the past 10 months I have been writing about a bio-chemical
corporation, Oravax, in relation to the so-called WNV (West Nile Virus)
epidemic in NYC. The V.P of Oravax, Dr. Thomas Monath has been working
behind the scenes with Mayor Giuliani, former OEM chief Jerry Hauer, Dr.
Cohen and the CDC since the very beginning of this issue.
From: Newsday 9/25/99-Deadly Discovery "Virologist Thomas Monath, one of
the country's leading authorities on mosquito-carried viruses, called
the discovery ``a bombshell,'' and added: `` This is the biggest
arbovirus story of the last 50 years. Wow!'' Monath, who works for
OraVax, a biotechnology company in Boston, said he has been working
closely with CDC investigators in New York since the encephalitis outbreak
began in late August. He is assisting federal scientists in trying to
figure out a way to deal with the new development."
As predicted, Oravax has now been given a grant from the N.I.H.
(National Institute of Health) to create a WNV vaccine. The theory I and
a number of other activists have been suggesting is that the entire WNV
panic has been created specifically in order to justify the mass
distribution of this very vaccine throughout the entire U.S.
Oravax was granted a license by the U.S. Army bio-warfare lab in Ft.
Dietrick in 1996 (Monath was previously a researcher at the same lab) to
manufacture a Japanese encephalitis vaccine derived from a
genetically-altered virus the Army itself created. WNV is a variation of
Japanese encephalitis. Numerous medical and scientific institutions,
many run by the Federal government, have been quietly experimenting
with WNV in NYC and the surrounding area for decades [see references
below]. Most of this research involved bio-warfare applications.
According to the press release and articles below the vaccine is a live,
attenuated vaccine (it contains live WN virus) and involves "the
construction of a chimeric virus in which the envelope genes of yellow
fever vaccine are replaced with the corresponding genes of the target
West Nile virus". In other words, the plan appears to be to expose the
entire nation orally to a genetically-modified form of WNV. Since
the vaccine is made from a genetically-altered strain there is no way to
know exactly what other theoretically beneficial or harmful genes may
have been added. Scientists in the field of GE foods
(genetically-altered foods) have already found evidence that genes in
the pollen of these foods can become incorporated into the DNA of
insects that pollinate the GE plants. In other words it is possible to
incorporate these genes into your own DNA simply by eating the food, or
in this instance, orally taking a vaccine.
[From: biotech_activists@iatp.org "Tappeser" tappeser@oeko.de
Organization: Oeko-Institute e.V. Date: Tue, 23 May 2000 15:37:25 +0100
Subject: new stories from Germany "The German Television ZDF reported
on Sunday May 21 that a German researcher found a gene transfer from
genetically engineered rapeseed to bacteria and fungi in the gut of
honey bees. Prof. Hans-Hinrich Kaatz from the Institut fĂĽr
Bienenkunde (Institute for bee research) at the University of Jena
experimented during the last three years with honey bees on an
experimental field with transgenic rapeseed in Saxony, Germany."]
Mayor Giuliani and his advisors have been massively spraying NYC with a
variety of toxic pesticides since last Fall, despite knowing that
experts in the field of mosquito control have determined that such
spraying actually increases the number of mosquitoes, makes succeeding
generations pesticide resistant and increases the incidence of
mosquitoes infected with transmissible viruses like WNV by as much as 15
times.
see: Are Mosquito Spray Pesticides Worsening the Encephalitis Problem?
http://www.chem-tox.com/brevard/index.htm
SOURCE: Journal of the American Mosquito Control Assoc,
Dec;13(4):315-25, 1997 Howard JJ, Oliver New York State Department of
Health, SUNY-College ESF, Syracuse 13210, USA.
Also see my articles on this
http://baltech.org/lederman/spray/
Considering the mild nature of WNV their actions appear to be intended
to increase WNV rather than to decrease it. Dr. Cohen implied as much
two days ago.
NY Post 8/1/2000-
SPRAY IT AIN'T SO! ROUND 2 ON S.I.
"Cohen said...Part of the reason for the new skeeter woes is that
between 10 and 20 percent of the bugs won't be killed by the pesticide
[the ones that are resistant to the chemicals] - and those that live
will reproduce, Cohen said....Cohen said the traps were nearly empty in
the first two days after the initial Staten Island spraying last month,
but now they're filling up again.
"This is not unexpected," he insisted."
That Dr. Cohen acknowledges he knows that the spraying would lead to new
generations of pesticide resistant mosquitoes supports the idea that the
spraying is actually intended to help create a demand for the vaccine,
which the NYC officials Major West Nile Virus Development- unquestionably
knew was already in development and testing.
What the real purpose of the vaccine is one can only guess at this
point.
From: NY Times 8/7/98
GERM DEFENSE PLAN IN PERIL AS ITS FLAWS ARE REVEALED.
If you carefully read the very long article this is excerpted from you
will see detailed evidence of how Dr. Monath, former Giuliani OEM
chief Jerry Hauer, the president of Rockefeller University (where they
have experimented with WNV for decades) and Dr. J. Craig Venter,
president of The Institute for Genomic Research (the co-researchers and
co-owners of the Human Genome Project) have been pressuring President
Clinton to spend billions on a nationwide vaccine program against germ
warfare.
EXCERPT: "In April, the president...and his top officials met at the
White House on April 10 with seven private scientists in the Truman
Room, where Cabinet meetings are held. For an hour, participants say,
the scientists discussed the germ topic and pushed for a vaccine
stockpile. Clinton's attending officials included the secretary of
defense, the attorney general, the secretary of health and human
services, the director of Central Intelligence and the president's
national security adviser. The scientists present were Dr. Frank Young,
a former head of the Food and Drug Administration, who moderated the
panel; Dr. Joshua Lederberg, president emeritus of Rockefeller
University; Dr. Lucille Shapiro, a biologist at Stanford University;
Jerome Hauer, head of emergency management for New York City; and Dr.
Barbara Rosenberg, a biological arms-control expert at the Federation of
American Scientists, a private group. The scientific panel also had two
industry experts, both with financial ties to vaccine work. ..Dr. Thomas
Monath was identified in a White House announcement as a vice president
of OraVax and a former official of the Centers for Disease Control and
the U.S. Army Medical Research Institute of Infectious Diseases, the
government's top body for defensive germ-warfare studies...Based in
Cambridge, Mass.,
OraVax was founded in 1990 to tap an emerging multi-billion-dollar market
in oral vaccines and antibodies to combat infectious diseases. But the
small company kept having problems getting beyond research and bringing
products to market. By 1996 and 1997, its survival at stake, OraVax
tried to win part of the Pentagon's expanding germ work as a
subcontractor to make smallpox and other vaccines.
By early this year, that work had failed to materialize and the
company's stock price was down 90 percent from $10 a share in the
initial public offering...."The way to handle it is to be open, so
people understand that I may have a potential bias," Monath said. "I
don't make it a business of taking advantage of situations in which I'm
asked to participate to push the OraVax agenda."
From:
http://info.med.yale.edu/EIINet/MonathSeminar.html
[Note how the VP of Oravax, manufacturer of the encephalitis vaccine
who is advising Giuliani on this crisis, was both a researcher at Ft.
Dietrick Bio-Warfare lab and a CDC scientist.] "Thomas Monath is one of
the world's leading arbovirologists. He is currently Vice- President of
Research and Medical Affairs at OraVax, Inc. in Cambridge,
Massachusetts.
In this position he is responsible for the scientific direction of
programs on vaccine development...Prior to this he was the Chief of the
Virology Division, U.S. Army Medical Research Institute of Infectious
Diseases at Fort Detrick in Maryland. In this position he was
responsible for the development of genetically engineered vaccines
against arthropod- borne and hemorrhagic fever viruses. Between 1974 and
1988 he was the Medical Director of the Division of Vector- Borne
Infectious Diseases at the Centers for Disease Control in Fort Collins,
Colorado." Peptide Awarded Grant by NIH to Develop West Nile Vaccine
CAMBRIDGE, England, 8/1/2000 /PRNewswire/ -- Peptide Therapeutics Group
plc (LSE: PTE.L) ("Peptide") announces that it has been awarded a
Fast-Track Small Business Innovative Research (SBIR) grant by the US
National Institutes of Health ("NIH") to develop an important new
vaccine to prevent West Nile virus disease ("West Nile")...
Fears are growing that another outbreak could occur this year. Infected
birds and mosquitoes have been detected over a wide area from New Jersey
to Massachusetts. Public health warnings have been issued to residents
of the affected States, and intensive mosquito control is underway in
many areas. There is no vaccine, cure or specific therapy against West
Nile virus disease.
The US government is actively pursuing a campaign to combat the disease,
including funding the development of vaccines for preventative use.
The West Nile vaccine will be developed using Peptide's proprietary
ChimeriVax(TM) technology. It will be a live, attenuated vaccine and
involves the construction of a chimeric virus in which the envelope
genes of yellow fever vaccine are replaced with the corresponding genes
of the target West Nile virus.
This approach has already been employed by Peptide to develop vaccines
against dengue fever (in pre-clinical development) and Japanese
encephalitis (due to commence Phase I trials shortly).
Dr. Thomas Monath, Vice President Research & Medical Affairs of Peptide,
said: "The advantages of ChimeriVax(TM) vaccines include their high
safety profile, ability to induce protection within a few days after a
single dose, and long-lasting immunity without the need for booster
doses. A ChimeriVax(TM) West Nile vaccine is therefore ideally suited
for use in an impending epidemic, where rapid immunization is required."
Dr. John Brown, Chief Executive of Peptide, said: "We are delighted to
have been selected by the US government to receive funding to continue
to develop our West Nile vaccine. The West Nile virus is one of the
most frightening to have emerged in recent years and there is no vaccine
available to protect against the disease. We are confident that
ChimeriVax(TM) can provide the technology to develop a vaccine that will
provide a rapid and effective solution."
For further information visit our web site at
www.peptide.co.uk .
08/01/2000 11:22 EDT
http://www.prnewswire.com
See:
http://www.biospace.com/
for an entire clearinghouse for bio-tech companies
Newsday 9/29/99 -
Area Labs Have Long Studied Virus
Yale, Rockefeller began tests in '50s page A28 " Epidemiologists suspect
that the West Nile virus has for the first time been isolated in humans
or animals in the Western Hemisphere, but the virus has for decades made
its home in several U.S. research laboratories, including Rockefeller
University in Manhattan and Yale University in New Haven, Conn. In fact,
investigators there were the first to grow and study the West Nile virus
in the United States. The work began in the 1950s when unidentified
viral samples from around the world arrived at Rockefeller on a steady
basis."
Newsday 5/9/2000
Mosquito From Asia Could Carry West Nile
"THE ASSOCIATED PRESS":
In Army tests at Fort Detrick in Frederick, Md., japonicus was found to
be the "most competent vector" [transmittter] for West Nile virus in a
laboratory setting, when compared with other mosquitoes."
From:
http://www.bioinfo.com/jev.html
[from Federal Register: March 22, 1996 (Volume 61, Number 57, Page
11812]
DEPARTMENT OF DEFENSE
Notice of Intent To Grant an Exclusive License of a U.S.
Government-Owned Patent Agency: U.S. Army Medical Research and Materiel
Command, DOD [Department of Defense].
Action: Notice. Summary: In accordance with 37 CFR 404.7 (a)(I)(i),
announcement is made of the intent to grant an exclusive,
royalty-bearing, revocable license of U.S. Patent Application Serial
Number 08/348,882, filed November 28, 1994 and entitled ``Infectious DNA
Clones of Japanese Encephalitis Virus and Attenuated Strains Japanese
Encephalitis Virus Made from the Clones'', to OraVax, Inc., 230 Albany
Street, Cambridge, Massachusetts 02139.
[Requests to the Army for further information should be directed to the
public affairs officer, Mr. Chuck Dasey (301) 619-2736] Robert
Lederman, President of A.R.T.I.S.T. (Artistsâ?T Response To Illegal State
Tactics)
ARTISTpres@aol.com (718) 743-3722
http://www.levymultimedia.com/lederman/index.htm
For an article on the Manhattan Institute go to
http://www.konformist.com/2000/rudyg.htm
If you would like to help oppose the spraying, please write to the No
Spray Coalition, PO Box 334, Peck Slip Station, NYC 10272-0334, or call
the No Spray hotline at (718) 670-7110.
Any funds you can send to help continue the lawsuit and this work are
greatly appreciated.
http://www.nospray.org/
For Lederman articles with more on this information see
http://baltech.org/spray/
http://Baltech.org/lederman/spray/
Newsday, 10/10/99 Bugged by Spraying
The loudest protests heard during the city's recent campaign of
insecticide spraying came from the city's tiny Green Party and the
artist-agitator Robert Lederman...Yesterday, the head of the mayor's
Office of Emergency Management, which took the lead in the assault on
the city's mosquito populace, dismissed such concerns as "irresponsible
environmental hysteria and stupidity."
"If they took a deep breath [of Malathion?] and looked at what we did
and what pains we went through to ensure that we did it right and
recognize that human life is at stake, they'd get the perspective," said
OEM Director Jerry Hauer.
AOL has been diverting and not sending my emails. PLEASE FORWARD THIS
FAR AND WIDE INCLUDING TO THE MEDIA-THANKS!
=====
Please visit my website "Emerging Diseases" and message board
http://goddess-of-fire.tripod.com/index-1.html
http://disc.server.com/Indices/93896.html
Patricia Doyle, PhD Investigator of Emerging Diseases
__________________________________________________
